Sensei Bio acquires Faeth Therapeutics

Sensei Bio agreed to acquire Faeth Therapeutics. Reported deal value: $200M. Status: Announced. Sector: biotechnology. Target headquarters context: Austin, Texas, United States.

This page summarizes publicly available information about the transaction as of 2026-02-18. Figures and status may change as filings and press coverage update.

Sidley Represents Sensei Biotherapeutics in Acquisition of Faeth Therapeutics Announcements Sidley Represents Sensei Biotherapeutics in Acquisition of Faeth Therapeutics February 18, 20 26 PDF A4 Sidley represented Sensei Biotherapeutics , Inc. , a clinical-stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, in its acquisition of Faeth Therapeutics Inc. , a clinical-stage biotechnology company developing multi-node therapies targeting tumor metabolism and signaling